Log In
BCIQ
Print this Print this
 

ReliNethra

  Manage Alerts
Collapse Summary General Information
Company Reliance Life Sciences
DescriptionAutologous composite human limbal epithelial graft
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationOrgan transplant
Indication DetailsGraft for corneal disorder
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today